Jan 25 (Reuters) - Ose Immunotherapeutics Sa:
* OSE IMMUNOTHERAPEUTICS RECEIVES NOTICE OF ALLOWANCE FOR NEW PATENT BY U.S. PATENT AND TRADEMARK OFFICE THAT FURTHER STRENGTHENS INTELLECTUAL PROPERTY PORTFOLIO AROUND TEDOPIÂ® IN IMMUNO-ONCOLOGY APPLICATIONS Source text for Eikon: Further company coverage: (Gdynia Newsroom)
 